drugset / Trial / NCT05605197
U87 CART in Treatment of Advanced Solid Tumor
Phase 1
Unknown
12 enrolled
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Shanghai 10th People's Hospital · collab
NaSingle-groupOpen-labelTreatment
Summary
This is a single center, open-label, phase 1 study to evaluate the safety and efficacy of U87 CART in treating advanced solid tumor .
Timeline
- Start
- 2022-10-19
- Primary completion
- 2024-12-31
- Completion
- 2025-10-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | U87 CAR-T | Cell therapy | 1e+06 cells | Intravenous |
| Subject | U87 CAR-T | Cell therapy | 1e+07 cells | Intravenous |
| Background | Cyclophosphamide | Other / unclassified | 250 mg/m2 | — |
| Background | Cyclophosphamide | Other / unclassified | 500 mg/m2 | — |